CA72-4 is high on its own and may or may not come down on its own.
CA72-4 is currently a clinical tumor screening marker, and its significant elevation is commonly found in gastrointestinal and ovarian tumors, such as ovarian cancer, colorectal cancer, and stomach cancer. In addition to malignant tumors, some benign diseases of the gastrointestinal tract, such as gastritis and gastric ulcer, and healthy people taking health care products may also show elevated levels of this indicator.
For the elevation of CA724 caused by benign diseases and taking health care products, with the improvement of the condition or stop taking health care products, it can be relieved on its own, which makes the value of CA72-4 decrease spontaneously. For malignant neoplastic diseases or benign diseases that are not in remission, there is often no spontaneous decrease in CA72-4.
Therefore, people with elevated CA72-4 need to consult a doctor for standardized diagnosis and treatment when necessary, so as not to delay the condition due to negligence.